The Role of Babesia bovis MSA-1 in Erythrocyte Invasion
牛巴贝虫 MSA-1 在红细胞侵袭中的作用
基本信息
- 批准号:6750121
- 负责人:
- 金额:$ 8.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-06-01 至 2006-05-31
- 项目状态:已结题
- 来源:
- 关键词:Babesiaantibody titeringantigen antibody reactionantisense nucleic acidbabesiosisbinding proteinsbiological modelsblocking antibodycell linecell sortingcowerythrocyte membranegene induction /repressiongene targetinggenetic translationhost organism interactionimmune adherence reactionimmunocytochemistryintracellular parasitismmolecular cloningplasmidsprotein biosynthesisprotein structure functionprotozoal antigensite directed mutagenesissurface antigenstransfection /expression vector
项目摘要
DESCRIPTION (provided by applicant): Apicomplexan parasites in the genera
Babesia and Plasmodium infect mature erythocytes and cause disease in animals
and humans. A principal vaccine strategy is to direct immune responses
against merozoite surface proteins and block entry into the host erythrocyte.
While parasite proteins involved in invasion have been identified, the
function of these proteins and the molecular mechanisms of invasion are major
gaps in our knowledge. I propose to use Babesia bovis infection of bovine
erythrocytes as a model to investigate the function of merozoite surface
proteins in invasion. Based on the ability of antibodies against B. bovis
merozoite surface antigen-1 (MSA-1) to prevent merozoite attachment to the
erythrocyte and inhibit erythrocyte invasion in vitro, MSA-l has been
postulated to mediate merozoite attachment to the erythrocyte. In addition,
breakthrough isolates in vaccinated cattle express allelic variants of MSA-1,
suggesting selection of MSA-1 variants under immune pressure. Therefore, I am
interested in better understanding the role of MSA-l in invasion with the goal
of defining conserved molecular targets for immunization. The research
outlined in this proposal will test the hypothesis that merozoite surface
antigen-1 (MSA-1) of Babesia bovis mediates erythrocyte invasion through
binding to the erythrocyte surface. The hypothesis will be tested through the
following specific aims: Specific aim 1: Determine if B. bovis MSA-1 binds to
the erythrocyte surface. Specific aim 2: Determine if inhibition of MSA-l
expression disrupts parasite binding to the erythrocyte. Specific aim 3:
Determine if disruption of the msa-l gene inhibits parasite binding to and
invasion of erythrocytes.
The primary purposes of this research are to increase our understanding of the
mechanisms of erythrocyte invasion used by babesial parasites, and to develop
a system for investigating the function of other babesia1 molecules using
genetic manipulation. The information obtained will expand our knowledge of
comparative invasion mechanims used by apicomplexan hemoparasites, including
Babesia and Plasmodium spp that infect humans. The results of this project,
as well as the transfection techniques that will be developed, will allow us
to begin targeting regions of functional significance in these proteins for
further study.
描述(由申请人提供): 顶复门寄生虫属
巴贝虫和疟原虫感染成熟红细胞并引起动物疾病
和人类。 主要的疫苗策略是引导免疫反应
对抗裂殖子表面蛋白并阻止进入宿主红细胞。
虽然参与入侵的寄生虫蛋白已被识别,
这些蛋白质的功能和入侵的分子机制是主要的
我们的知识差距。 我建议用牛巴贝斯虫感染牛
以红细胞为模型研究裂殖子表面功能
入侵中的蛋白质。 基于抗牛双歧杆菌抗体的能力
裂殖子表面抗原 1 (MSA-1) 可防止裂殖子附着在
MSA-l 在体外具有抑制红细胞侵袭的作用
推测介导裂殖子附着于红细胞。 此外,
接种疫苗的牛中突破性分离株表达 MSA-1 等位基因变体,
建议在免疫压力下选择 MSA-1 变体。 因此,我是
有兴趣更好地了解 MSA-l 在入侵中的作用,目标是
定义免疫的保守分子靶点。 研究
该提案中概述的将检验裂殖子表面的假设
牛巴贝虫抗原1(MSA-1)通过介导红细胞侵袭
与红细胞表面结合。 该假设将通过以下方式进行检验
具体目标如下: 具体目标 1:确定 B. bovis MSA-1 是否结合
红细胞表面。 具体目标 2:确定 MSA-1 是否受到抑制
表达破坏寄生虫与红细胞的结合。 具体目标3:
确定 msa-l 基因的破坏是否会抑制寄生虫与
红细胞的侵袭。
这项研究的主要目的是加深我们对
巴贝斯寄生虫利用红细胞入侵的机制,并发展
研究其他巴贝虫1分子功能的系统
基因操纵。 获得的信息将扩展我们的知识
顶端复门血寄生虫使用的比较入侵机制,包括
感染人类的巴贝虫属和疟原虫属。 这个项目的结果,
以及将要开发的转染技术,将使我们能够
开始针对这些蛋白质中具有功能意义的区域
进一步研究。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tanya LeRoith其他文献
Tanya LeRoith的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tanya LeRoith', 18)}}的其他基金
Expansion of Molecular and MALDI-ToF Testing for Veterinary Diagnostics
扩大兽医诊断的分子和 MALDI-ToF 测试
- 批准号:
10192502 - 财政年份:2017
- 资助金额:
$ 8.24万 - 项目类别:
Expansion of Molecular and MALDI-ToF Testing for Veterinary Diagnostics
扩大兽医诊断的分子和 MALDI-ToF 测试
- 批准号:
9475383 - 财政年份:2017
- 资助金额:
$ 8.24万 - 项目类别:
FDA CVM Vet-LRN Veterinary Diagnostic Laboratory Program
FDA CVM Vet-LRN 兽医诊断实验室计划
- 批准号:
8723646 - 财政年份:2012
- 资助金额:
$ 8.24万 - 项目类别:
FDA CVM Vet-LRN Veterinary Diagnostic Laboratory Program
FDA CVM Vet-LRN 兽医诊断实验室计划
- 批准号:
9117713 - 财政年份:2012
- 资助金额:
$ 8.24万 - 项目类别:
FDA CVM Vet-LRN Veterinary Diagnostic Laboratory Program
FDA CVM Vet-LRN 兽医诊断实验室计划
- 批准号:
9126295 - 财政年份:2012
- 资助金额:
$ 8.24万 - 项目类别:
FDA CVM Vet-LRN Veterinary Diagnostic Laboratory Program
FDA CVM Vet-LRN 兽医诊断实验室计划
- 批准号:
9323167 - 财政年份:2012
- 资助金额:
$ 8.24万 - 项目类别:
FDA CVM Vet-LRN Veterinary Diagnostic Laboratory Program
FDA CVM Vet-LRN 兽医诊断实验室计划
- 批准号:
8502817 - 财政年份:2012
- 资助金额:
$ 8.24万 - 项目类别:
FDA CVM Vet-LRN Veterinary Diagnostic Laboratory Program
FDA CVM Vet-LRN 兽医诊断实验室计划
- 批准号:
8537886 - 财政年份:2012
- 资助金额:
$ 8.24万 - 项目类别:














{{item.name}}会员




